Studies to Explore DNA Replication Proteins in Functional Assemblies through Intrinsically Disordered Domains

通过本质无序结构域探索功能组装中 DNA 复制蛋白的研究

基本信息

  • 批准号:
    10576326
  • 负责人:
  • 金额:
    $ 53.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Our long-term goal is to define the molecular mechanisms by which DNA replication is initiated and regulated in metazoans. Cells rely on two AAA+ ATPases, ORC and Cdc6, along with a third factor, Cdt1, to load a latent helicase (the Mcm2-7 complex) as a double hexamer onto replication origins. Upon entering S-phase, Mcm2-7 is activated by the GINS and Cdc45 accessory factors, melting the duplex origin. The resultant CMG (Cdc45/Mcm2-7/GINS) assembly unwinds parental DNA strands and coordinates DNA synthesis by the replisome. Recently, we discovered that metazoan replication initiation factors – specifically the Orc1 subunit of ORC, as well as Cdc6 and Cdt1 – use long, intrinsically disordered regions (IDRs) to bind DNA and partition into liquid phase condensates (LPCs). This and other observations led us to a new functional model for replication, whereby initiator IDRs and LPC propensity controls not only chromatin association, but also Mcm2-7 loading, partner selection, and heterochromatin status. In Aim 1, we will resolve the molecular determinants by which initiator IDRs facilitate condensation. In Aim 2, we will define how initiator IDRs control partner-protein interactions. In Aim 3, we will establish how Orc1 uses its IDR to interface with pericentric heterochromatin through interactions with other LPC-forming proteins such as Hp1. Significant outcomes expected to result from the proposed work include: 1) defining how initiator IDRs – which we have shown to be a novel class of condensate-promoting element – interface with DNA and each other, 2) uncovering new proteins capable of associating with initiation factors, and 3) explaining how ORC connects to the formation and maintenance of genome organization and expression. IDRs have been predominantly thought to serve either as flexible linkers that allow mobility between ordered domains, or as segments that undergo an induced-fit transition into folded structures through protein-protein interactions. Recent work shows that IDRs can fulfill another role in specifying partner-protein interactions and driving the formation of membraneless compartments through liquid phase separation. Our proposal will establish how IDRs can lead to specificity for co-association and potential compartmentalization with origins and other factors. Our efforts will inform areas of molecular biology where IDRs are used to manifest phase-separated compartments or protein/nucleic-acid clustering for functional purposes. As ~25% of proteomes are predicted to be unstructured, the utility of such insights will be broadly significant.
项目摘要 我们的长期目标是确定DNA复制启动和调控的分子机制, 后生动物。细胞依赖于两种AAA+ ATP酶ORC和Cdc 6,沿着第三种因子Cdt 1, 解旋酶(Mcm 2 -7复合物)作为双六聚体连接到复制起点上。进入S相后,Mcm 2 -7 由GINS和Cdc 45辅助因子激活,使双链体起源熔化。生成的CMG (Cdc 45/Mcm 2 -7/GINS)组装解开亲本DNA链并协调DNA合成。 复制体 最近,我们发现后生动物的复制起始因子-特别是ORC的Orc 1亚基, 以及Cdc 6和Cdt 1-使用长的内在无序区(IDR)结合DNA并分配到液体中 相冷凝物(LPC)。这一点和其他观察使我们产生了一种新的复制功能模型, 启动子IDR和LPC倾向不仅控制染色质缔合,而且控制Mcm 2 -7加载、配偶体 选择和异染色质状态。在目标1中,我们将解决引发剂的分子决定因素 IDR有助于浓缩。在目标2中,我们将定义起始IDRs如何控制伴侣-蛋白质相互作用。在 目的3,我们将建立Orc 1如何使用其IDR通过相互作用与臂间异染色质相互作用 与其他LPC形成蛋白如Hp 1。预期拟议工作将产生的重大成果 包括:1)定义引发剂IDR--我们已经证明是一类新的促进缩合物的 元件-与DNA和彼此的界面,2)发现能够与起始相关联的新蛋白质 因素,以及3)解释ORC如何连接到基因组组织的形成和维持, 表情 IDR主要被认为是作为柔性接头,允许有序连接之间的流动性, 结构域,或作为通过蛋白质-蛋白质间的诱导配合转变为折叠结构的片段 交互.最近的工作表明,IDR可以在指定伴侣蛋白质相互作用中发挥另一个作用, 通过液相分离驱动无膜室的形成。我们的建议将 确定IDR如何导致与起源的共同关联和潜在区室化的特异性, 其他因素我们的努力将告知分子生物学领域,其中IDR用于显示相分离 区室或蛋白质/核酸簇用于功能目的。据预测,约25%的蛋白质组 如果没有结构化,这种见解的效用将具有广泛的意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES M BERGER其他文献

JAMES M BERGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES M BERGER', 18)}}的其他基金

Understanding and exploiting DNA topoisomerases in cancer biology
了解和利用癌症生物学中的 DNA 拓扑异构酶
  • 批准号:
    10296437
  • 财政年份:
    2021
  • 资助金额:
    $ 53.78万
  • 项目类别:
Understanding and exploiting DNA topoisomerases in cancer biology
了解和利用癌症生物学中的 DNA 拓扑异构酶
  • 批准号:
    10473793
  • 财政年份:
    2021
  • 资助金额:
    $ 53.78万
  • 项目类别:
Studies to Explore DNA Replication Proteins in Functional Assemblies through Intrinsically Disordered Domains
通过本质无序结构域探索功能组装中 DNA 复制蛋白的研究
  • 批准号:
    10400225
  • 财政年份:
    2021
  • 资助金额:
    $ 53.78万
  • 项目类别:
Studies to Explore DNA Replication Proteins in Functional Assemblies through Intrinsically Disordered Domains
通过本质无序结构域探索功能组装中 DNA 复制蛋白的研究
  • 批准号:
    10177581
  • 财政年份:
    2021
  • 资助金额:
    $ 53.78万
  • 项目类别:
Studies to Explore DNA Replication Proteins in Functional Assemblies through Intrinsically Disordered Domains
通过本质无序结构域探索功能组装中 DNA 复制蛋白的研究
  • 批准号:
    10579065
  • 财政年份:
    2021
  • 资助金额:
    $ 53.78万
  • 项目类别:
Structure/Function Studies of DNA Replication Initiation
DNA复制起始的结构/功能研究
  • 批准号:
    8123707
  • 财政年份:
    2010
  • 资助金额:
    $ 53.78万
  • 项目类别:
Development of Novel Topoisomerase and Replication Initiator Assays
新型拓扑异构酶和复制引发剂检测的开发
  • 批准号:
    8010546
  • 财政年份:
    2010
  • 资助金额:
    $ 53.78万
  • 项目类别:
Development of Novel Topoisomerase and Replication Initiator Assays
新型拓扑异构酶和复制引发剂检测的开发
  • 批准号:
    8278540
  • 财政年份:
    2010
  • 资助金额:
    $ 53.78万
  • 项目类别:
Development of Novel Topoisomerase and Replication Initiator Assays
新型拓扑异构酶和复制引发剂检测的开发
  • 批准号:
    8076371
  • 财政年份:
    2010
  • 资助金额:
    $ 53.78万
  • 项目类别:
Biochemical Analyses of Type II DNA Topoisomerases
II 型 DNA 拓扑异构酶的生化分析
  • 批准号:
    7909236
  • 财政年份:
    2009
  • 资助金额:
    $ 53.78万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 53.78万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 53.78万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.78万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.78万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 53.78万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.78万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 53.78万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 53.78万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 53.78万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.78万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了